Skip to main content
Premium Trial:

Request an Annual Quote

France Launches Council to Boost High-Tech Industries

NEW YORK, July 8 - French biotech advocate Philippe Pouletty and a host of industrial and scientific leaders in France have teamed up to create a council to improve the legal and economic climate for high-tech business.


The Strategic Council for Innovation, which includes entrepreneurs, investors, research institute directors, economists, and lawyers, will promote legislation and governmental programs designed to ease regulations and increase R&D spending.


Its aims include:


·        Monitoring and ranking French and European high-tech performance;

·        Pressing for new legislation to ease regulations on the high-tech sector and encourage private medical research foundations;

·        Doubling government research funding within five years;

·        Increasing international mobility and networking; and

·        Boosting government subsidies for entrepreneurs.


Members include former French Minister of Research François d'Aubert, Institut National de la Santé et de la Recherche Médicale Director General Cedric Bannel, Centre National de la Recherche Scientifique Life Sciences Director Bernard Pau, and Pasteur Institut Licensing Director Christian Policard.


Pouletty is president of the trade organization France Biotech and of Objectif 2010, a biotechnology entrepreneur group.


Last fall, the French government pledged €150 million, or roughly $148 million, in loan guarantees and venture funding for biotech as part of an effort to bring the country's medical technology industry up to snuff.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.